Detalles de la búsqueda
1.
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Acta Haematol
; 127(1): 34-42, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22005133
2.
Effectiveness of the Combination of Rituximab and Standard Chemotherapeutic Regimens in Previously Untreated Patients with Chronic Lymphocytic Leukaemia in Real-Life: Results from a Noninterventional Study (CILI Study).
Pathol Oncol Res
; 25(2): 535-540, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30361908
3.
Comparative Analysis of Multicolor Flow Cytometry and Immunohistochemistry for the Detection of Disseminated Tumor Cells.
Appl Immunohistochem Mol Morphol
; 26(5): 305-315, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426528
4.
Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).
Pathol Oncol Res
; 24(2): 199-205, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432650
Resultados
1 -
4
de 4
1
Próxima >
>>